Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

35.65
Delayed Data
As of 3:59pm ET
 -0.34 / -0.94%
Today’s Change
33.60
Today|||52-Week Range
55.51
-34.07%
Year-to-Date

Today’s Trading

Previous close35.99
Today’s open36.31
Day’s range35.37 - 36.66
Volume3,528,345
Average volume (3 months)6,855,812
Market cap$19.3B
Dividend yield--
Data as of 3:59pm ET, 12/05/2016

Growth & Valuation

Earnings growth (last year)-27.35%
Earnings growth (this year)+10.47%
Earnings growth (next 5 years)+7.03%
Revenue growth (last year)+21.91%
P/E ratio15.4
Price/Sales2.84
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+2.74+2.69%
VRTXVertex Pharmaceutica...+0.05+0.07%
BAXBaxter International...-0.12-0.27%
ZTSZoetis Inc+0.72+1.47%
Data as of 4:03pm ET, 12/05/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.43
Annual revenue (last year)$9.5B
Annual profit (last year)$847.6M
Net profit margin8.95%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts


Search for Jobs